|
UBE2V2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.057800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.364500E-03 |
| Normal-vs-Stage2 |
8.019500E-02 |
| Normal-vs-Stage3 |
3.263600E-01 |
| Normal-vs-Stage4 |
8.923200E-01 |
| Stage1-vs-Stage2 |
7.026600E-01 |
| Stage1-vs-Stage3 |
2.732200E-01 |
| Stage1-vs-Stage4 |
1.730770E-01 |
| Stage2-vs-Stage3 |
5.492800E-01 |
| Stage2-vs-Stage4 |
2.490000E-01 |
| Stage3-vs-Stage4 |
4.724000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.143900E-03 |
| Normal-vs-AfricanAmerican |
7.300700E-03 |
| Normal-vs-Asian |
7.321400E-01 |
| Caucasian-vs-AfricanAmerican |
6.676600E-01 |
| Caucasian-vs-Asian |
7.635400E-01 |
| AfricanAmerican-vs-Asian |
6.270000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.555990E-04 |
| Normal-vs-Female |
6.429400E-01 |
| Male-vs-Female |
2.195900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.734260E-02 |
| Normal-vs-Extreme_Weight |
4.736700E-03 |
| Normal-vs-Obese |
7.567900E-02 |
| Normal-vs-Extreme_Obese |
9.845900E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.462400E-01 |
| Normal_Weight-vs-Obese |
3.806200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.087200E-01 |
| Extreme_Weight-vs-Obese |
3.451400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.690000E-01 |
| Obese-vs-Extreme_Obese |
4.196400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.719000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.017800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.358800E-04 |
| Normal-vs-Age(81-100Yrs) |
6.478700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.524570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.742400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.966500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.196450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.646000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.242000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.004100E-04 |
| Normal-VS-Type2 PRCC |
1.664080E-02 |
| Normal-VS-KIRP CIMP |
1.465020E-01 |
| Normal-VS-Unclassified PRCC |
7.373800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.311000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.989900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.480400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.062500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.985600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.022400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.596690E-04 |
| Normal-vs-N1 |
2.801800E-01 |
| Normal-vs-N2 |
5.107400E-01 |
| N0-vs-N1 |
2.762900E-04 |
| N0-vs-N2 |
3.675600E-01 |
| N1-vs-N2 |
4.081600E-01 |
|
|
